229 related articles for article (PubMed ID: 8752102)
1. Characterization of inhibitor-sensitive and -resistant adenosine transporters in cultured human fetal astrocytes.
Gu JG; Nath A; Geiger JD
J Neurochem; 1996 Sep; 67(3):972-7. PubMed ID: 8752102
[TBL] [Abstract][Full Text] [Related]
2. [3H]adenosine transport in synaptoneurosomes of postmortem human brain.
Gu JG; Kala G; Geiger JD
J Neurochem; 1993 Jun; 60(6):2232-7. PubMed ID: 8492128
[TBL] [Abstract][Full Text] [Related]
3. Transport and metabolism of D-[3H]adenosine and L-[3H]adenosine in rat cerebral cortical synaptoneurosomes.
Gu JG; Geiger JD
J Neurochem; 1992 May; 58(5):1699-705. PubMed ID: 1560227
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the abilities of nitrobenzylthioinosine, dilazep, and dipyridamole to protect human hematopoietic cells from 7-deazaadenosine (tubercidin).
Cass CE; King KM; Montaño JT; Janowska-Wieczorek A
Cancer Res; 1992 Nov; 52(21):5879-86. PubMed ID: 1394215
[TBL] [Abstract][Full Text] [Related]
5. Effects of nucleoside transport inhibitors and adenine/ribose supply on ATP concentration and adenosine production in cardiac myocytes.
Kalsi KK; Smolenski RT; Yacoub MH
Mol Cell Biochem; 1998 Mar; 180(1-2):193-9. PubMed ID: 9546646
[TBL] [Abstract][Full Text] [Related]
6. Differential cardioprotection with selective inhibitors of adenosine metabolism and transport: role of purine release in ischemic and reperfusion injury.
Abd-Elfattah AS; Jessen ME; Lekven J; Wechsler AS
Mol Cell Biochem; 1998 Mar; 180(1-2):179-91. PubMed ID: 9546645
[TBL] [Abstract][Full Text] [Related]
7. Nucleoside transporter subtype expression: effects on potency of adenosine kinase inhibitors.
Sinclair CJ; Powell AE; Xiong W; LaRivière CG; Baldwin SA; Cass CE; Young JD; Parkinson FE
Br J Pharmacol; 2001 Nov; 134(5):1037-44. PubMed ID: 11682452
[TBL] [Abstract][Full Text] [Related]
8. Adenine/ribose supply increases adenosine production and protects ATP pool in adenosine kinase-inhibited cardiac cells.
Smolenski RT; Kalsi KK; Zych M; Kochan Z; Yacoub MH
J Mol Cell Cardiol; 1998 Mar; 30(3):673-83. PubMed ID: 9515042
[TBL] [Abstract][Full Text] [Related]
9. Species differences in sensitivity of nucleoside transport in erythrocytes and cultured cells to inhibition by nitrobenzylthioinosine, dipyridamole, dilazep and lidoflazine.
Plagemann PG; Woffendin C
Biochim Biophys Acta; 1988 Apr; 969(1):1-8. PubMed ID: 3349106
[TBL] [Abstract][Full Text] [Related]
10. Involvement of bidirectional adenosine transporters in the release of L-[3H]adenosine from rat brain synaptosomal preparations.
Gu JG; Foga IO; Parkinson FE; Geiger JD
J Neurochem; 1995 May; 64(5):2105-10. PubMed ID: 7722493
[TBL] [Abstract][Full Text] [Related]
11. Adenosine uptake and deamination regulate tonic A2a receptor facilitation of evoked [3H]acetylcholine release from the rat motor nerve terminals.
Correia-de-Sá P; Ribeiro JA
Neuroscience; 1996 Jul; 73(1):85-92. PubMed ID: 8783232
[TBL] [Abstract][Full Text] [Related]
12. Role of adenosine uptake and metabolism by blood cells in the antiplatelet actions of dipyridamole, dilazep and nitrobenzylthioinosine.
Dawicki DD; Agarwal KC; Parks RE
Biochem Pharmacol; 1985 Nov; 34(22):3965-72. PubMed ID: 4062970
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological characterization of rapidly accumulated adenosine by dissociated brain cells from adult rat.
Geiger JD; Johnston ME; Yago V
J Neurochem; 1988 Jul; 51(1):283-91. PubMed ID: 3379409
[TBL] [Abstract][Full Text] [Related]
14. Molecular identification of the equilibrative NBMPR-sensitive (es) nucleoside transporter and demonstration of an equilibrative NBMPR-insensitive (ei) transport activity in human erythroleukemia (K562) cells.
Boleti H; Coe IR; Baldwin SA; Young JD; Cass CE
Neuropharmacology; 1997 Sep; 36(9):1167-79. PubMed ID: 9364472
[TBL] [Abstract][Full Text] [Related]
15. Nucleoside transporter-mediated uptake and release of [3H]L-adenosine in DDT1 MF-2 smooth muscle cells.
Foga IO; Geiger JD; Parkinson FE
Eur J Pharmacol; 1996 Dec; 318(2-3):455-60. PubMed ID: 9016938
[TBL] [Abstract][Full Text] [Related]
16. Effects of iodotubercidin on adenosine kinase activity and nucleoside transport in DDT1 MF-2 smooth muscle cells.
Parkinson FE; Geiger JD
J Pharmacol Exp Ther; 1996 Jun; 277(3):1397-401. PubMed ID: 8667202
[TBL] [Abstract][Full Text] [Related]
17. Adenosine metabolism in human whole blood. Effects of nucleoside transport inhibitors and phosphate concentration.
Dawicki DD; Agarwal KC; Parks RE
Biochem Pharmacol; 1988 Feb; 37(4):621-6. PubMed ID: 3342099
[TBL] [Abstract][Full Text] [Related]
18. [3H]adenosine transport in DDT1 MF-2 smooth muscle cells: inhibition by metabolites of propentofylline.
Parkinson FE; Mukherjee K; Geiger JD
Eur J Pharmacol; 1996 Jul; 308(1):97-102. PubMed ID: 8836637
[TBL] [Abstract][Full Text] [Related]
19. [3H]dipyridamole binding to nucleoside transporters from guinea-pig and rat lung.
Shi MM; Young JD
Biochem J; 1986 Dec; 240(3):879-83. PubMed ID: 3827876
[TBL] [Abstract][Full Text] [Related]
20. Evidence that adenine nucleotides modulate nucleoside-transporter function. Characterization of uridine transport in chromaffin cells and plasma membrane vesicles.
Delicado EG; Casillas T; Sen RP; Miras-Portugal MT
Eur J Biochem; 1994 Oct; 225(1):355-62. PubMed ID: 7925456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
